Literature DB >> 9508332

Unexpected high prevalence of secondary bacterial infection in patients with mycetoma.

A O Ahmed, E S Abugroun.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9508332      PMCID： PMC104645          DOI： 10.1128/JCM.36.3.850-851.1998

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  5 in total

1.  A preliminary study on the ultrastructure of Actinomadura pelletieri and its host tissue reaction.

Authors:  A H Fahal; E A el Toum; A M el Hassan; E S Mahgoub; S A Gumaa
Journal:  J Med Vet Mycol       Date:  1994

2.  The host tissue reaction to Madurella mycetomatis: new classification.

Authors:  A H Fahal; E A el Toum; A M el Hassan; E S Mahgoub; S A Gumaa
Journal:  J Med Vet Mycol       Date:  1995 Jan-Feb

3.  Internal fistula formation: an unusual complication of mycetoma.

Authors:  A H Fahal; A R Sharfi; H E Sheik; A M el Hassan; E S Mahgoub
Journal:  Trans R Soc Trop Med Hyg       Date:  1996 Sep-Oct       Impact factor: 2.184

Review 4.  Mycetoma.

Authors:  M Magana
Journal:  Int J Dermatol       Date:  1984-05       Impact factor: 2.736

Review 5.  Mycetoma.

Authors:  A H Fahal; M A Hassan
Journal:  Br J Surg       Date:  1992-11       Impact factor: 6.939
  5 in total
  11 in total

1.  Mycetoma clinically masquerading as squamous cell carcinoma: case report and literature review.

Authors:  Saira B Momin; Blakely S Richardson; Michael G Bryan; James Q Del Rosso; Narciss Mobini
Journal:  J Clin Aesthet Dermatol       Date:  2009-02

2.  Development of a species-specific PCR-restriction fragment length polymorphism analysis procedure for identification of Madurella mycetomatis.

Authors:  A O Ahmed; M M Mukhtar; M Kools-Sijmons; A H Fahal; S de Hoog; B G van den Ende; E E Zijlstra; H Verbrugh; E S Abugroun; A M Elhassan; A van Belkum
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

3.  Histological diagnosis of madura foot (mycetoma): a must for definitive treatment.

Authors:  Kiran Alam; Veena Maheshwari; Shruti Bhargava; Anshu Jain; Uroos Fatima; Ershad Ul Haq
Journal:  J Glob Infect Dis       Date:  2009-01

4.  Active matrix metalloprotease-9 is associated with the collagen capsule surrounding the Madurella mycetomatis grain in mycetoma.

Authors:  Kirsten Geneugelijk; Wendy Kloezen; Ahmed H Fahal; Wendy W J van de Sande
Journal:  PLoS Negl Trop Dis       Date:  2014-03-27

Review 5.  The mycetoma knowledge gap: identification of research priorities.

Authors:  Wendy W J van de Sande; El Sheikh Maghoub; Ahmed H Fahal; Michael Goodfellow; Oliverio Welsh; Ed Zijlstra
Journal:  PLoS Negl Trop Dis       Date:  2014-03-27

6.  Reconstructive Surgery for Mycetoma: Is There a Need to Establish an Algorithm?

Authors:  Mohamed Abdelrahman; Eltaib A Saad; Gamal M Abdulla; Abdelsamie Mohamed
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-04-24

7.  The disabling consequences of Mycetoma.

Authors:  Mustafa Abbas; Peter Siordet Scolding; Abubaker Ahmed Yosif; Roa Fath El Rahman; Melka O El-Amin; Mohamed Kamal Elbashir; Nora Groce; Ahmed Hassan Fahal
Journal:  PLoS Negl Trop Dis       Date:  2018-12-10

8.  Association of eumycetoma and schistosomiasis.

Authors:  Jaap J van Hellemond; Alieke G Vonk; Corné de Vogel; Rob Koelewijn; Norbert Vaessen; Ahmed H Fahal; Alex van Belkum; Wendy W J van de Sande
Journal:  PLoS Negl Trop Dis       Date:  2013-05-23

9.  The combination of amoxicillin-clavulanic acid and ketoconazole in the treatment of Madurella mycetomatis eumycetoma and Staphylococcus aureus co-infection.

Authors:  Najwa A Mhmoud; Ahmed Hassan Fahal; El Sheikh Mahgoub; Wendy W J van de Sande
Journal:  PLoS Negl Trop Dis       Date:  2014-06-19

10.  Molecular identification of Actinomadura madurae isolated from a patient originally from Algeria; observations from a case report.

Authors:  Arezki Izri; Mohanad Aljundi; Typhaine Billard-Pomares; Youssouf Fofana; Anthony Marteau; Theo Ghelfenstein Ferreira; Sophie Brun; Frederic Caux; Mohammad Akhoundi
Journal:  BMC Infect Dis       Date:  2020-11-11       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.